Mauro Rosales

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

Leticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al. · ACS Pharmacology & Translational Science · 2020 · 45 citations · Full text

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

Mauro Rosales, George Perez, Ailyn C. Ramòn et al. · Biomedicines · 2021 · 23 citations · Full text

Protein Kinase Ck2, Immunology, Cell Death +17

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

Ailyn C. Ramòn, George Perez, Evelín Caballero et al. · Viruses · 2022 · 12 citations · Full text

Molecular Virology, Protein Kinase Ck2, Viral Pathogenesis +13

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

George Perez, Mauro Rosales, Ailyn C. Ramòn et al. · Biomedicines · 2022 · 11 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Apoptosis +18

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

Mauro Rosales, Arielis Rodríguez‐Ulloa, Vladimir Besada et al. · Cells · 2021 · 10 citations · Full text

Immunology, Cell Death, Molecular Biology +20